1-3 of 3
Charles Farber, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Relapse Of Follicular Lymphoma After R-CHOP Uniquely Defines Patients At High Risk For Death: An Analysis From The National Lymphocare Study

Carla Casulo, MD, Michelle Byrtek, PhD, Keith L. Dawson, DNP, RN, Xiaolei Zhou, MS, Charles Farber, MD, Christopher R. Flowers, MD, MS, John D. Hainsworth, MD, Brian K Link, MD, Andrew D. Zelenetz, MD, PhD, Jonathan W. Friedberg, MD
Journal: Blood
Blood (2013) 122 (21): 510.
https://doi.org/10.1182/blood.V122.21.510.510
Published: 2013
Journal Articles

Monotherapy with Subcutaneous (SC) Injections of Low Doses of Humanized Anti-CD20 Veltuzumab Is Active in Chronic Lymphocytic Leukemia (CLL)

Matt Kalaycio, MD, O George Negrea, MD, Rebecca Elstrom, MD, Charles Farber, MD, PhD, Heather Horne, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD
Journal: Blood
Blood (2012) 120 (21): 192.
https://doi.org/10.1182/blood.V120.21.192.192
Published: 2012
Journal Articles

Patterns of Care for Patients with Chronic Lymphocytic Leukemia (CLL): The Connect ® CLL Disease Registry

Jeff Sharman, MD, Christopher R Flowers, MD, Mark Weiss, MD, David Grinblatt, MD, Charles Farber, MD, PhD, Neil Kay, MD, Thomas Kipps, MD, Nicole Lamanna, MD, Chris Pashos, PhD, Ian W Flinn, MD, Mark Kozloff, MD, Susan Lerner, MS, Arlene S Swern, PhD, Kristen A Sullivan, MBA, Thomas K. Street, RPh, Michael Keating, MBBS
Journal: Blood
Blood (2011) 118 (21): 2864.
https://doi.org/10.1182/blood.V118.21.2864.2864
Published: 2011